Buy TRT HCG Kit — Synedica Testosterone + HCG Daily Injection Pen
The Synedica TRT + HCG Injection Pen Kit is the most advanced format to buy a TRT HCG kit for testosterone and gonadotropin combination research. Each kit provides a 14-day supply of daily microdose subcutaneous injections combining 15mg Testosterone Cypionate and 150iu Human Chorionic Gonadotropin (HCG) per dose — delivered via a single pre-loaded pen with 14 needles and a full dosing guide included.
This dual-compound daily microdosing format is the most researched protocol for studying stable androgen levels alongside LH-mimicking gonadotropin activity — addressing two of the most studied mechanisms in male hormone research simultaneously: exogenous testosterone delivery and endogenous testicular stimulation via HCG-mediated LH receptor activation.
What Is the TRT + HCG Research Protocol?
Testosterone Replacement Therapy (TRT) research investigates the physiological effects of exogenous testosterone administration on androgen-dependent pathways. A well-documented finding in TRT research is the suppression of the hypothalamic-pituitary-gonadal (HPG) axis — elevated systemic testosterone signals the hypothalamus and pituitary to reduce GnRH and LH secretion, which can cause intratesticular testosterone to drop by up to 94% and suppress spermatogenesis (Coviello et al., 2005, Journal of Clinical Endocrinology & Metabolism).
HCG (Human Chorionic Gonadotropin) is a glycoprotein hormone that acts as a structural and functional analog of luteinizing hormone (LH). In TRT research models, concurrent HCG administration is investigated for its ability to maintain intratesticular testosterone production via direct Leydig cell stimulation — counteracting the LH suppression induced by exogenous testosterone. This makes the combined TRT + HCG kit the preferred dual-compound format for studying androgen replacement alongside gonadal axis preservation.
What Is in Each Daily Dose?
| Compound | Dose per day | Total per kit | Mechanism studied |
|---|---|---|---|
| Testosterone Cypionate | 15mg | 210mg (14 days) | Androgen receptor activation, stable systemic testosterone signalling |
| HCG (Human Chorionic Gonadotropin) | 150iu | 2,100iu (14 days) | LH receptor activation, Leydig cell stimulation, intratesticular testosterone maintenance |
Why Daily Microdosing? Research Advantages of the Synedica Protocol
Most TRT research uses weekly or bi-weekly injection protocols, which produce pronounced peak-and-trough testosterone level fluctuations between doses. The Synedica TRT HCG kit uses a daily microdosing subcutaneous protocol — delivering smaller doses each day to model stable systemic testosterone concentrations without the peaks and troughs associated with weekly injection schedules. This makes the Synedica kit the preferred format for research investigating stable androgen level maintenance alongside concurrent gonadal axis activity.
| Protocol | Weekly injection | Synedica daily microdose |
|---|---|---|
| Testosterone delivery | Single large bolus weekly | 15mg daily — stable daily delivery |
| Level stability | Peak-and-trough fluctuations | Consistent daily serum levels |
| HCG co-administration | Separate vial — requires separate injection | 150iu HCG per dose in same pen |
| Needle requirement | Multiple needles, separate vials | Single pen — 1 needle per day |
What Is Included in the TRT HCG Injection Pen Kit?
- 1 × Pre-loaded TRT + HCG daily microdose injection pen — 14-day supply
- 14 × Disposable fine-gauge needles (1 per daily administration)
- 1 × Full instruction and dosing guide booklet
- Each dose: 15mg Testosterone Cypionate + 150iu HCG
What Is Testosterone Cypionate (TRT)?
Testosterone Cypionate is a long-acting ester of testosterone — one of the most widely used forms of exogenous testosterone in research models due to its stable release profile and well-characterised pharmacokinetics. The cypionate ester extends testosterone’s half-life to approximately 7–8 days in injectable oil-based formulations; in the Synedica daily microdose aqueous format, it is delivered in smaller daily volumes for stable androgen signalling research without the accumulation peaks associated with standard IM administration.
What Is HCG (Human Chorionic Gonadotropin)?
HCG is a glycoprotein hormone structurally and functionally analogous to luteinizing hormone (LH). It binds to LH receptors on Leydig cells in the testes, stimulating intratesticular testosterone production and supporting spermatogenesis. In TRT research, concurrent HCG administration at 150–500iu doses is studied for its ability to maintain testicular function and intratesticular testosterone levels — counteracting the HPG axis suppression caused by exogenous testosterone. The Synedica kit delivers 150iu HCG per daily dose alongside 15mg Testosterone Cypionate in a single pre-loaded pen.
R&D Applications
The Synedica TRT + HCG Injection Pen Kit is produced exclusively for the following controlled research and development applications:
- Daily microdose testosterone delivery and androgen receptor signalling studies
- HPG axis suppression and LH-analog gonadotropin co-administration research
- Intratesticular testosterone maintenance during exogenous androgen studies
- Leydig cell stimulation and spermatogenesis pathway investigation
- Testosterone Cypionate pharmacokinetics and stable serum level modelling
- Combined androgen + gonadotropin dual-compound injection pen research
- Formulation development for subcutaneous daily microdose delivery systems
Frequently Asked Questions
Where can I buy a TRT HCG kit?
The Synedica TRT + HCG Injection Pen Kit is available directly at synedica.us. A 14-day research supply with 1 pen, 14 needles, and a dosing guide — in stock with fast USA shipping.
What does each dose in the TRT HCG kit contain?
Each daily dose contains 15mg Testosterone Cypionate and 150iu HCG (Human Chorionic Gonadotropin) in a single pre-loaded subcutaneous injection pen. The 14-day kit delivers 210mg total Testosterone Cypionate and 2,100iu total HCG.
Why is HCG used alongside TRT in research?
When exogenous testosterone is administered, the HPG axis detects elevated systemic testosterone and reduces LH and GnRH secretion — which can suppress intratesticular testosterone by up to 94% and impair spermatogenesis. HCG mimics LH and directly stimulates Leydig cells to maintain intratesticular testosterone production alongside exogenous TRT. This dual-compound approach is the most studied protocol for investigating androgen replacement with concurrent gonadal axis preservation.
What is daily microdosing in TRT research?
Daily microdosing delivers small daily doses of testosterone (15mg) instead of a single large weekly injection — producing stable daily serum testosterone levels without the peak-and-trough fluctuations of weekly bolus protocols. Research consistently shows daily subcutaneous microdosing produces more stable androgen levels, making it the preferred format for controlled testosterone studies.
What is Testosterone Cypionate?
Testosterone Cypionate is a long-acting testosterone ester with an approximate 7–8 day half-life. It is one of the most widely used forms of exogenous testosterone in research due to its stable pharmacokinetics and well-characterised release profile. In the Synedica daily microdose format, it is delivered in 15mg daily aqueous subcutaneous doses.
How is the Synedica TRT HCG kit different from separate TRT and HCG vials?
Standard TRT and HCG research requires two separate vials, separate reconstitution steps, separate syringes, and two separate injections per session. The Synedica TRT HCG kit combines both compounds in a single pre-loaded pen — one daily injection, no reconstitution, no separate measuring, no additional equipment required.
⚠️ All Synedica products are produced exclusively for controlled laboratory research and development applications. Not for human or animal consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.